alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Breadcrumb

1. Home

2. Print 

3. Pdf 

4. Node 

5. Entity Print 

Tilapia Lake Virus

Last Modified: 

Print

Tilapia lake virus (TiLV) is a serious disease of farmed and wild tilapia that causes

high mortality in infected fish. APHIS works with fish health partners to protect U.S.

tilapia producers and growers from TiLV.
The first-ever detection of TiLV in the United States happened in 2019 in three tilapia

aquaculture facilities in Idaho, Wyoming, and Colorado. APHIS worked with the

States and facility owners to quickly contain and eradicate TiLV.

While TiLV is not present in the United States, it is an emerging disease

internationally. APHIS has trade restrictions in place to protect the U.S. tilapia

industry from TiLV.

What To Look For

TiLV-infected fish may show one or more of the following symptoms:

Loss of appetite

Abdominal swelling

Black discoloration

Skin abrasions

Ocular degeneration

Bulging eyes

Renal congestion

Scale protrusion

Pallor

How To Prevent This Disease

TiLV survives in both fresh and brackish water and can transmit to tilapia through

the water. Fish-to-fish contact is another way TiLV spreads between fish.

Biosecurity and good husbandry help stop the introduction and spread of TiLV. If

you're a tilapia producer, here's what you can do:

Purchase live fish and germplasm from TiLV-free sources.

Quarantine and monitor all new fish stocks.

Disinfect and properly dispose of water used to transport live fish.

Clean and disinfect pools and equipment regularly.
How It Is Treated

There is no treatment for TiLV.

Report Signs of Animal Disease

Producers or owners who suspect an animal disease should contact their

veterinarian to evaluate the animal or herd. Find an accredited veterinarian.

Animal health professionals (veterinarians; diagnostic laboratories; public health,

zoo, or wildlife personnel; and others) report diagnosed or suspected cases of

nationally listed reportable animal diseases to APHIS District Offices and to the State

animal health official as applicable under State reporting regulations. 

Controlling Tilapia Lake Virus

Current Status

TiLV is not present in the United States. The only detection of TiLV in the United

States took place in 2019. APHIS quickly contained and eradicated that outbreak.

Diagnostic Testing

TiLV testing is conducted in the United States by several laboratories.

Contact your State or local aquatic animal health laboratory to see if they can test

for TiLV before sending samples.

Trade Restrictions Protect U.S. Fish Health

APHIS restricts the import of all live fish, fertilized eggs, and gametes from TiLVsusceptible species. These imports must meet U.S. import requirements, including

being accompanied by a USDA import permit, an official health certificate, and

veterinary inspection. Learn more about these restrictions.

Reports and Assessments
Assessment of the Risk of Introduction of Tilapia Lake Virus (TiLV) by Live

Tilapia Imported to Terminal Markets(November 2020)

Analysis of U.S. Imports/Exports of Live Tilapia and Eggs/Milt(January 2020)
Navigate to Homepage
Search
Main navigation
  

        
              Explore the Capitol Campus
                          Art
                            Buildings & Grounds
                            Capitol Hill Facts
                            Visitor Resources
                            Our Blog
                            What We Do
                          Areas of Expertise
                            Programs & Ceremonies
                            Projects
                            Publications
                            Strategic Objectives
                            About Us
                          Who We Are
                            History of the AOC
                            News & Notices
                            Organizational Structure
                            Partnerships & Recognition
                            Work With UsSearch Breadcrumb
    HomeExplore the Capitol CampusGrounds Features
State of Georgia Tree
        
                  The Basics
      
Materials
    Flowering Dogwood

Year
    1983

Location
      
Capitol Square, N.E.

U.S. Capitol Grounds

                  View on Map

Text on the Plaque

U.S. Capitol Grounds 
Memorial Tree

*Cornus florida*
(Flowering Dogwood)

Planted by 
Senator Sam Nunn

For State of Georgia

March 11, 1983
          
    
      Image Gallery
    
    Tree for the state of Georgia on the U.S. Capitol Grounds during summer.

Tree for the state of Georgia on the U.S. Capitol Grounds during summer.
    Tree for the state of Georgia on the U.S. Capitol Grounds during winter.

Tree for the state of Georgia on the U.S. Capitol Grounds during winter.
    Tree for the state of Georgia on the U.S. Capitol Grounds during spring.

Tree for the state of Georgia on the U.S. Capitol Grounds during spring.

      Previous Image
        Next Image

          Tree for the state of Georgia on the U.S. Capitol Grounds during summer.
      Tree for the state of Georgia on the U.S. Capitol Grounds during winter.
      Tree for the state of Georgia on the U.S. Capitol Grounds during spring. Serve. Preserve. Inspire.

              Contact Us
                            Accountability
                            Hill Staff Resources
                            AOC Staff Resources
Utility
  

        
              Privacy Policy
                            Image Terms of Use
                            Inspector General
                            U.S. Botanic Garden
                            U.S. Capitol Visitor CenterFacebook
	Twitter
	Flickr
	YouTube
	Instagram
	Subscribe
# THE STATE OF TEXAS

M A N D A T E

*********************************************

TO THE 3RD DISTRICT COURT OF ANDERSON CO UNTY, GREETING:

Before our Court of Appeals for the 12th Court of Appeals District of Texas, on the 3rd

day of December, 2014 , the ca use upon appeal to revise or reverse your judgment between

ROBERT LYNN PRIDGEN , Appellant

NO. 12

- 13

- 00136

- CR; Trial Court No. 29956

Opinion by James T. Worthen, Chief Justice.

THE STATE OF TEXAS , Appellee

was determined; and therein our said Court mad e its order in these words:

“ THIS CAUSE came to be heard on the appellate record and briefs filed herein, and the

same being considered, it is the opinion of this court that there was no error in the judgment.

It is therefore ORDERED, ADJUDGED and DECR EED that the judgment of the court

below be in all things affirmed , and that the decision be certified to the court below for

observance. ”

WHEREAS, WE COMMAND YOU to observe the order of our said Court of Appeals

for the Twelfth Court of Appeals District of Texas in this behalf, and in all things have it duly

recognized, obeyed, and executed.

WITNESS, THE HONORABLE JAMES T. WORTHEN , Chief Justice of our Court

of Appeals for the Twelfth Court of Appeals District, with the Seal thereof affixed, at the City o f

Tyler, this the 29 th day of July , 201 5

.

CATHY S. LUSK, CLERK

By:

_______________________________ Chief Deputy Clerk
# C_2019399EN.01005102.xml

| 25.11.2019 | EN | Official Journal of the European Union | C 399/51 |
| --- | --- | --- | --- |

25.11.2019

EN

Official Journal of the European Union

C 399/51

---

Judgment of the General Court of 17 September 2019 — Pharmadom v EUIPO — IRF (MediWell)

(Case T-502/18) (1)

(EU trade mark - Opposition proceedings - Application for EU figurative mark MediWell - Earlier national word mark WELL AND WELL and earlier national figurative mark well & well LES PHARMACIENS - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EU) 2017/1001)

(2019/C 399/62)

Language of the case: English

Parties

Applicant: Pharmadom (Boulogne-Billancourt, France) (represented by: M.-P. Dauquaire, lawyer)

Defendant: European Union Intellectual Property Office (represented by: S. Bonne and H. O’Neill, acting as Agents)

Other party to the proceedings before the Board of Appeal of EUIPO: IRF s. r. o. (Bratislava, Slovakia)

Re:

Action brought against the decision of the Fifth Board of Appeal of EUIPO of 8 June 2018 (Case R 6/2018-5), relating to opposition proceedings between Pharmadom and IRF.

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Pharmadom to pay the costs. |
| --- | --- |

2.

Orders Pharmadom to pay the costs.

---

(1)  OJ C 373, 15.10.2018.

---
IN THE COURT OF CRIMINAL APPEALS

OF TEXAS

NOS. PD-0117-21 & PD-0118-21

JAMES EARL WARREN, Appellant

v.

THE STATE OF TEXAS

ON STATE’S PETITION FOR DISCRETIONARY REVIEW

FROM THE TWELFTH COURT OF APPEALS

SMITH COUNTY

YEARY, J., filed a dissenting opinion in which SLAUGHTER, J., joined.

DISSENTING OPINION

For the reasons set out in my dissenting opinion in Dulin v. State, ___ S.W.3d ___, 

Nos. PD-0856-19 & PD-1857-19, 2021 WL 1202400 (Tex. Crim. App. Mar. 31, 2021), I 

respectfully dissent to the Court’s disposition of the State’s petition for discretionary 

review.

FILED: May 12, 2021

DO NOT PUBLISH
#### State v. Jones

17855

11/02/94

Affirmed
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### National Science Foundation

The National Science Board's (NSB) NSB-NSF Commission on Merit Review hereby gives notice of the scheduling of a videoconference meeting for the transaction of National Science Board business pursuant to the National Science Foundation Act and the Government in the Sunshine Act.

# TIME AND DATE:

Wednesday, December 13, 2023, from 12:00-1:30 p.m. Eastern.

# PLACE:

This meeting will be held in person and by videoconference through the National Science Foundation headquarters at 2415 Eisenhower Ave., Alexandria, VA 22314.

# STATUS:

One portion open and one portion closed.

# MATTERS TO BE CONSIDERED:

*Open:*                         12:00-1:00 p.m. Matters to be considered—Commission Chair's opening remarks; Discussion of Diversity, Equity, Inclusion, and                               ( print page 86160)                            Accessibility in Merit Review; Closing remarks.                    

*Closed:*                         1:00-1:30 p.m. Matters to be considered—Chairman's opening remarks regarding the agenda; Discussion of data collection workplan and instruments; Closing remarks.                    

# CONTACT PERSON FOR MORE INFORMATION: 

                        Point of contact for this meeting is: (Chris Blair,                         *cblair@nsf.gov*), 703/292-7000. Members of the public can observe the public portion of this meeting through a YouTube livestream. The YouTube link will be available from the NSB web page.                    

Ann E. Bushmiller,

Senior Legal Counsel to the National Science Board.

[FR Doc. 2023-27278 Filed 12-8-23; 11:15 am]

BILLING CODE 7555-01-P
# C_2023045EN.01003502.xml

| 6.2.2023 | EN | Official Journal of the European Union | C 45/35 |
| --- | --- | --- | --- |

6.2.2023

EN

Official Journal of the European Union

C 45/35

---

Order of the General Court of 30 November 2022 — Deichmann v Commission

(Case T-131/18) (1)

(2023/C 45/53)

Language of the case: English

The President of the Sixth Chamber has ordered that the case be removed from the register.

---

(1)  OJ C 152, 30.4.2018.

---
17700

#### Hirakawa v. Gentry Development Co.

Affirmed
# C_2020137EN.01002401.xml

| 27.4.2020 | EN | Official Journal of the European Union | C 137/24 |
| --- | --- | --- | --- |

27.4.2020

EN

Official Journal of the European Union

C 137/24

---

Judgment of the Court (Second Chamber) of 5 March 2020 (request for a preliminary ruling from the Cour d’appel de Bruxelles — Belgium) — Viasat UK Ltd and Viasat Inc. v Institut belge des services postaux et des télécommunications (IBPT)

(Case C-100/19) (1)

(Reference for a preliminary ruling - Approximation of laws - Telecommunications sector - Harmonised use of radio spectrum in the 2 GHz frequency bands for the implementation of systems providing mobile satellite services - Decision No 626/2008/EC - Article 4(1)(c), Article 7(1), and Article 8(1) - Complementary ground components - Authorisations issued by Member States - Requirement for operators to provide service coverage for a certain percentage of the population and the territory - Non-compliance - Effect)

(2020/C 137/31)

Language of the case: French

Referring court

Cour d’appel de Bruxelles

Parties to the main proceedings

Applicants: Viasat UK Ltd and Viasat Inc.

Defendant: Institut belge des services postaux et des télécommunications (IBPT)

Other parties to the proceedings: Inmarsat Ventures Ltd c.o. and Eutelsat SA

Operative part of the judgment

Article 8(1) of Decision No 626/2008/EC of the European Parliament and of the Council of 30 June 2008 on the selection and authorisation of systems providing mobile satellite services (MSS), read in conjunction with Article 7(1) thereof, must be interpreted as meaning that, where it is established that an operator selected in accordance with Title II of that decision and authorised to use the radio spectrum pursuant to Article 7 thereof has failed to provide mobile satellite services by means of a mobile satellite system by the deadline set in Article 4(1)(c)(ii) of Decision No 626/2008, the competent authorities of the Member States are not entitled to refuse to grant the authorisations necessary for the provision of complementary ground components of mobile satellite systems to that operator on the ground that that operator has failed to honour the commitment given in its application.

---

(1)  OJ C 131, 8.4.2019.

---
Attention 

Sheep and 

Goat Owners! 

Most sheep and goats moving in commerce

must have official scrapie tags.

To purchase o ̃icial scrapie ear tags, your flock 

must have a flock ID number. You must provide it 

to the tag company when you order tags. Please 

call 1-866-USDA-Tag (866-873-2824) to request a 

flock ID number or to place a first-time tag order. 

Scan here for the most 

up-to-date scrapie tag 

information. 

Are You New

to the Sheep and Goat 

Identification Program? 

The U.S. Department of Agriculture (USDA) 

will provide up to 100 plastic flock ID tags 

free-of-charge to first-time participants 

(as long as funds last). 

AllFlex USA, Inc. 

Phone: 833-SCRAPIE (833-727-2743) 

Fax: 972-338-3445 

Email: scrapiefullaf@merck.com 

Online: www.allflex.global/na/product/scrapie-tags/ 

• Regular and Scrapie-Free Flock Certification Program 

(SFCP) plastic tags 

• Radio frequency ID (RFID) 

• Plastic ear tags in several colors 

National Band & Tag Company Shearwell North America, Inc. 

Phone: 800-778-6014 

Email: SalesUSA@shearwell.com 

Online: www.shearwell.com 

• Regular and SFCP plastic tags 

• RFID 

• Plastic ear tags in several colors 

USDA-Approved Official Scrapie Tag Manufacturers

Tag applicators are di ̃erent for each company’s tags. You must purchase applicators at your own expense. 

They are not included with tags provided by USDA. 

USDA is an equal opportunity provider, employer, and lender. 

Issued September 2023 

APHIS-23-033 

Premier 1 Supplies, LLC 

Phone: 800-282-6631 

Fax: 800-346-7992 

Email: info@premier1supplies.com 

Online: www.premier1supplies.com 

• Regular and SFCP plastic tags 

• Plastic ear tags in several colors 

Phone: 859-261-2035 

Fax: 859-261-8247 

Email: tags@nationalband.com 

Online: www.nationalband.com/ 

• Metal ear tags in several colors
<TABLE> <S> <C>


<ARTICLE> 5
<LEGEND>
The schedule contains summary financial information extracted from the
financial statements and is qualified in its entirety by reference to such
financial statements.
</LEGEND>
<MULTIPLIER> 1
       
<S>                           <C>
<PERIOD-TYPE>                 YEAR
<FISCAL-YEAR-END>             NOV-30-1997
<PERIOD-END>                  NOV-30-1997
<CASH>                          3,733,652
<SECURITIES>                    2,375,570
<RECEIVABLES>                   8,981,236
<ALLOWANCES>                       54,000
<INVENTORY>                    26,061,702
<CURRENT-ASSETS>               44,153,185
<PP&E>                         10,020,892
<DEPRECIATION>                  5,353,453
<TOTAL-ASSETS>                 54,221,463
<CURRENT-LIABILITIES>           5,988,628
<BONDS>                        15,433,614
<PREFERRED-MANDATORY>                   0
<PREFERRED>                         4,981
<COMMON>                           35,572
<OTHER-SE>                     28,264,342
<TOTAL-LIABILITY-AND-EQUITY>   54,221,463
<SALES>                        51,351,803
<TOTAL-REVENUES>               51,351,803
<CGS>                          25,841,733
<TOTAL-COSTS>                  25,841,733
<OTHER-EXPENSES>                        0
<LOSS-PROVISION>                        0
<INTEREST-EXPENSE>              1,253,103
<INCOME-PRETAX>                 1,671,324
<INCOME-TAX>                      610,000
<INCOME-CONTINUING>             1,559,309
<DISCONTINUED>                          0
<EXTRAORDINARY>                         0
<CHANGES>                               0
<NET-INCOME>                    1,559,309
<EPS-PRIMARY>                         .41
<EPS-DILUTED>                         .41
        


</TABLE>
EXHIBIT 32.2

          CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED
            PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of E Com Ventures, Inc. (the "Company")
of Form 10-Q for the period ending July 30, 2005 as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), I, A. Mark Young,
Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that, to my knowledge:

      1.    The Report fully complies with the requirements of Section 13(a) or
            15(d) of the Securities Exchange Act of 1934; and

      2.    The information contained in the Report fairly presents, in all
            material respects, the financial condition and results of operations
            of the Company.


                                             By:   By: /S/ A. Mark Young
                                                   -----------------------
                                                   A. Mark Young
                                                   Chief Financial Officer
                                                   December 13, 2005
<TABLE>
<CAPTION>
                                  EXHIBIT 11.1
                              EASTON BANCORP, INC.
                        COMPUTATION OF EARNINGS PER SHARE
                        QUARTER ENDED SEPTEMBER 30, 1999


                                                     Three Months         Nine Months
                                                        Ended                Ended
                                                  September 30, 1999   September 30, 1999
                                                  -------------------  -------------------
<S>                                               <C>                  <C>
Net income                                        $           284,872  $           398,868
                                                  ===================  ===================


Average shares outstanding                                    560,318              560,318
Basic earnings per share                          $              0.51  $              0.71
                                                  ===================  ===================


Average shares outstanding                                    560,318              560,318
Dilutive average shares outstanding under
  warrants and options                                        207,800              207,800
Exercise price                                    $             10.00  $             10.00
Assumed proceeds on exercise                      $         2,078,000  $         2,078,000
Average market value                              $             12.50  $             12.33
Less:  Treasury stock purchased with assumed
  proceeds from exercise of warrants and options
                                                              166,240              168,486
Adjusted average shares-diluted                               601,878              599,632
Diluted earnings per share                        $              0.47  $              0.67
                                                  ===================  ===================
</TABLE>

     The stock of the Company is not traded on any public exchange.  The average
market  values  are  derived from trades known to management.  Private sales may
occur  where  management  of  the  Company  is  unaware  of  the  sales  price.


<PAGE>
#### Duarte v. State

16702

11/02/94

Affirmed